PerkinElmer to Use Orchid Tech to Develop, Sell SNP-Diagnostic Assays

Jul 09, 2002

NEW YORK, July 9 - PerkinElmer will develop and sell fluorescence-based SNP-diagnostic assays gleaned from genotyping technology owned by Orchid Bioscience, the companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Interleukin Genetics to Liquidate Assets
Agilent Acquires Population Genetics Technologies' Molecular, Sample Barcoding IP
Illumina Settles One Patent Dispute With Qiagen; Faces Separate Suit From Columbia, Qiagen
NCI Begins Enrollment in Precision Medicine Trial for Childhood Cancers
OncoDNA, Everything Genetic Sign Distribution Deal
Luminex Receives FDA Clearance for C. Diff Assay

The Scan

Helix Launches 'App Store'

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

More CAR-T Therapies Sought

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Telomeres of Spawning Salmon

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

This Week in PLOS

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

Main menu